Yang ST, Liu HH, Liu CH, Wang LW, et al. Bevacizumab is associated with a higher gastrointestinal/genitourinary fistula or perforation risk in cervical cancer patients undergoing pelvic radiotherapy. Int J Gynaecol Obstet 2024 May 15. doi: 10.1002/ijgo.15609.
PMID: 38746971